In 1991, Ukraine experienced a return of epidemic diphtheria after decades of control that had resulted in !40 sporadic cases reported every year. Increased incidence was first recorded in Kiev, Lviv, and Odessa. By 1993, the epidemic had spread to 150% of the oblasts (provinces) in the country, and by 1995, all regions were affected. In 1995, at the peak of the epidemic, 15000 cases and 1200 deaths were reported. As in Russia, 180% of these cases were diagnosed in persons 16-59 years old. In 1993, the government of Ukraine initiated a program of increased immunization among children and at-risk adults, and by 1995, a mass immunization strategy was adopted in an effort to arrest the epidemic, which was increasing exponentially. In 1996, the number of cases started to decrease, and data from 1998 indicate that the downward trend has continued. It is likely that the diphtheria epidemic in Ukraine started among children, who had been left vulnerable due to inadequate childhood immunizations, and then quickly spread to inadequately protected adults.
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Background
Diphtheria surveillance has been conducted in Ukraine since 1878. Until 1914, diphtheria incidence rates ranged from 171 to 857 cases per 100,000 population. Vaccination programs against the disease were first introduced in the region in 1932, and incidence rates rapidly decreased to 16/100,000 population by 1941. The first major immunization campaign was conducted between 1959 and 1964. Following this campaign, the Soviet Union introduced routine childhood immunization with diphtheria-tetanus toxoids and whole-cell pertussis vaccine (DTP), which was to be followed by childhood booster doses of diphtheria-tetanus toxoids vaccine (DT) combined with adolescent and adult booster doses of tetanus-diphtheria toxoids vaccine (Td). Following these measures, the number of diphtheria cases in Ukraine decreased sharply, dropping to !1 case/ 1,000,000 population by the 1970s (figure 1).
From 1970 to 1981, the annual number of cases did not exceed 43 (incidence rate, 0.09/100,000). Transmission was never completely interrupted, however, and isolated outbreaks continued to occur, primarily among children, throughout the 1970s and 1980s, and the disease maintained a low-level en-demicity in several regions of the country. In the mid-1980s, following several years of decline in the public health infrastructure, which included a drop in DTP coverage rates among children, there was a resurgence of diphtheria in the Soviet Union. The resurgence occurred primarily in the major urban centers of western Russia [1] , and smaller increases were also recorded in Ukraine.
By 1991, the first year of its independence from the Soviet Union, Ukraine experienced a return of epidemic diphtheria, and sharp increases in incidence were recorded in Kiev, Lviv, and Odessa. By 1993, the epidemic had spread to more than half of the oblasts (provinces) in the country and, by 1995 all regions were affected. As in Russia, 180% of these cases were diagnosed in 16-to 59-year-old adults. In 1993, the Ministry of Health (MOH) of Ukraine initiated a diphtheria vaccination campaign targeted at both children and adults, and by 1995, they had adopted a mass immunization strategy aimed at stopping the epidemic, which by then was increasing exponentially.
The antigen content of diphtheria vaccine is measured in limit of flocculation units (Lf). The diphtheria component of the combined DTP for infant immunizations is formulated at 6.7-25 Lf per dose (.5 mL), and that of DT is formulated at 6.7-12.5 Lf. Because of the risk of reactions in adults who have been sensitized due to prior immunizations, adult doses of Td manufactured in Europe and the United States contain not more than 2 Lf diphtheria toxoid; however, Russian-produced Td is formulated at 5 Lf.
In 1980, the total Lf content received by children (primary and booster series) by the time they reached 12 years of age . This latter amount is ∼20% of the Lf content of the complete series of diphtheria vaccines given to children in the United States and Western Europe. The vaccination schedule was also modified in 1986 by increasing intervals between doses. The schedule called for three doses of DTP given between 3 and 6 months of age, with three booster doses by age 16 (table 1) . This schedule was changed in 1992 to include a fourth booster vaccine, and it was changed again in 1996 to include a fifth booster vaccine dose at 18 years.
Descriptive Epidemiology, Diphtheria Epidemic, 1991-1997
Methods. The following epidemiologic data are contained in a computerized surveillance database maintained by the MOH of Ukraine. Samples from all clinically suspected diphtheria cases were cultured, and isolates were biotyped and tested for toxigenicity. Age, residence, and immunization history are recorded on case reporting forms from data contained in health records maintained at regional health facilities. Denominator data were obtained from biannual censuses carried out by health workers for routine planning purposes in their respective districts.
Incidence. The epidemic of diphtheria in Ukraine was first recognized in 1991 in the major urban areas of Kiev, Lviv, and Odessa, in the center, west, and south of the country, respectively. At the time, the susceptible population (i.e., those with neither naturally nor vaccine-acquired immunity) was estimated by serology surveys to be ∼41% in rural areas and 44% in urban areas (MOH, unpublished data). Following a brief decline in the number of cases during the first half of 1994, a second epidemic wave hit the country in late 1994 and 1995, peaking in the fourth quarter of 1995 with an annual incidence of ∼10.2 cases/100,000 population (figure 1). This was a 10-fold increase in the incidence rate compared with that for 1990.
The second epidemic surge was initially confined to the southern Black Sea regions of the Autonomous Republic of Crimea, Mikolaivska, Odeska, Khersonska, and Zaporizhska oblasts, and to the city of Kiev, but by mid 1995 it had spread in a sweeping arc from the southwest of the country across the east and north through the industrial and coal mining regions of Dnipropetrovska, Donetska, Luganska, Kharkivska, and Sumska oblasts (figure 2). The incidence of diphtheria began to sharply decrease in late 1995, and in 1996, the incidence was the lowest it had been in 2.5 years (6/100,000 population). In 1997, incidence rates decreased further, reaching 2.6/100,000 population, and by 1998, the incidence of diphtheria had decreased to !1.5 cases/100,000 population. There were sharp age-and sex-specific differences in the risk and severity of diphtheria disease during the epidemic in Ukraine. Historically, diphtheria had been a disease of children. During the epidemic, however, 180% of the cases were among persons 115 years old, and 2 age groups, those 15-17 and those 40-49 years old, shared the highest incidence rates (table 2). While disease incidence was roughly equally distributed between boys and girls !10 years of age, there was a sharp increase in cases among females relative to 16-to 19-year-old males. By the age of 25, women were almost twice as likely as men to be infected with diphtheria, a differential that remained throughout adulthood.
During 1992-1997, 43% of the reported diphtheria cases were unvaccinated (i.e., they had no record of having ever received vaccine) (table 3). The proportion of unvaccinated cases increased with age, reflecting the vaccination coverage for the different age groups at the time of the epidemic. Among children, 80% of the cases were fully vaccinated. Among adults, the proportion of cases who were unimmunized ranged from 46% in the 20-to 29-year-old age group to 65% in persons 150 years.
Mortality. Between 1992 and 1998, there were 669 deaths attributed to diphtheria, reflecting an overall case-fatality rate (CFR) of 3.7% (table 2). The age distribution of fatal cases differed from the overall incidence. In contrast to overall incidence, which was highest among women and those 16-19 and 40-49 years old, deaths from diphtheria were concentrated among children !10 years old and adults 135 years old. The CFR was higher for males in every age group except the very youngest. This sex difference in case fatality was greatest for adults 130 years old, and among the oldest cases, death resulted almost twice as often for men than for women.
Most (70%) fatal cases of diphtheria were unvaccinated, and the proportion of fatal cases who were unvaccinated ranged from 52% to 100% in the different age groups. Among 5-to 14-year-old children who died from diphtheria, 24% had been fully immunized (according to the immunization schedule at the time). This high proportion, the highest among fatal cases, can be partly explained by the fact that in the second half of the 1980s, children were often vaccinated with Td, which contains less diphtheria toxoid than does DTP, or with half dose of DTP. There was a marked difference in vaccination status between fatal and non-fatal cases, particularly among the younger age groups. Among children 0-3 years old, in particular, fatal cases were three to four times more likely to have been unvaccinated than were non-fatal cases.
Cases in rural areas were, overall, more than twice as likely to result in death than were cases in urban areas (CFR: 6.2% vs. 2.8%). Cases 16-29 years old had the lowest overall CFR; however, it was over six times higher among rural (3.4%) versus urban (0.5%) cases. This excess severity in outcome among rural cases may be due to reduced access to adequate treatment, or it could be a result of lowered case detection (i.e., perhaps only the more severe cases sought treatment in rural areas), or it could be a combination of the two factors.
Laboratory Results
In 1994, 71% of patients with clinical diphtheria had a culture positive for Corynebacterium diphtheriae. Eighty-two percent of the isolates were toxigenic, and of these, 87% were biotype gravis and 13% were biotype mitis. In 1995, 89% of the patients suspected of having diphtheria had a culture positive for C. diphtheriae. Of all the isolates, 81% were toxigenic and 86% were biotype gravis.
In 1996, samples from 2590 suspected clinical cases of diphtheria were tested, and 1839 (71%) had a culture positive for toxigenic C. diphtheriae. Of those, 91% were biotype gravis and 10% were mitis. In comparison, in 1990, 71% of all isolates were toxigenic, and of those, 55% were biotype mitis.
Control Measures
Mass campaign strategy. Prior to 1993, the MOH's immunization strategy was targeted to children, and while immunization plans were developed to vaccinate all children in the country, implementation was not strictly monitored and coverage was not accurately assessed. In 1993, the MOH began an aggressive campaign to immunize adults belonging to certain high-risk groups, primarily those in service industries (teachers, students, and health care, civil service, transport, and restaurant workers). In April 1994, following an appeal from the Ukrain- ian government for assistance in providing sufficient vaccine for this effort, the international community began delivery of humanitarian shipments of 55 million doses of Td vaccine for adult immunizations. The first shipments were received in July 1994, distributed by the MOH, and used in accordance with this targeted-risk group strategy.
By early 1995, it was evident that the selective target-group immunization strategy was not arresting the epidemic. Consequently, in February 1995, at an international conference called by the government of Ukraine and the World Health Organization (WHO) and attended by advisors from the MOH, WHO, the Program for Appropriate Technology in Health, the Centers for Disease Control and Prevention (CDC), the International Federation of Red Cross and Red Crescent Societies, UNICEF, and the United States Agency for International Development, Ukraine adopted an ambitious mass-immunization strategy in which all 16-to 59-year-old adults were to receive at least one dose of Td vaccine, and those between 30 and 49 years of age were to receive additional doses, following recommendations by WHO and CDC. These additional doses were indicated by CDC research, which suggested that a significant proportion of this population may have been inadequately primed to respond to a single booster dose of reduced diphtheria toxoid [2, 3] . In fact, the original policy was three-tiered, with those 16-29 and 50-59 years old receiving one dose, those 30-39 years old receiving two doses, and those 40-49 years old receiving three doses. This age-specific schedule was later changed to provide three doses to the 30-to 39-year-old age group; however, it was eventually rejected to reflect the de facto policy of the oblasts, which followed a single schedule, in which all adults у16 years old were to receive three doses.
This evolving dosage schedule led to some confusion in the field, the central MOH, and international organizations with regard to computing and interpreting coverage statistics, and it proved to be a major obstacle to attempts to monitor vaccine consumption and wastage. The strategy called for the initial first doses to be administered during intensive 10-day campaigns, organized in sets of oblasts, during which all adults, regardless of past vaccination history, were to be given one dose of Td. Subsequent doses were to be administered 1 month and 6-12 months later.
Coverage. The first campaigns were organized and carried [4] . A population-based, case-control study conducted in urban and rural areas of Zaporizhska 9 months later measured coverage among controls to be 163% [5] . This same study estimated the overall efficacy of the threedose schedule to be 190%. Over the next 18 months, campaigns were conducted in all 27 oblasts and administrative regions of the country. Oblast reports for 1996, along with retrospective vaccination numbers provided by oblasts for 1995 (before system-wide, standardized reporting was initiated) suggest that ∼85% of the adult population was immunized, using the official Ukrainian definition of three Td doses within a year, during that 2-year mass immunization period. Looking at only adult incidence data from 1995 and 1996, years during which the mass campaign strategy was carried out, the large majority of cases continued to come from among the unimmunized and partially immunized population.
Discussion
The diphtheria epidemic, which peaked in 1995 in Ukraine with 15000 cases, began to abate in 1996. In all but one oblast, disease incidence was lower in 1996 than it had been in 1995, and for many oblasts, particularly those that were hardest hit by the epidemic in 1995, the 1996 incidence was lower than it had been in 1993, and the 1997 incidence was lower than it had been in 1992; furthermore, on the basis of provisional data for 1998, the decrease in disease incidence continued in 1998. This decrease is consistent across all age groups. It is impossible to determine with certainty whether the decrease seen since late 1995 is solely due to vaccination during this period. However, the following observations strongly suggest that the immunization program has been effective. The incidence in Ukraine never approached the levels seen in neighboring Russia, although there is no apparent demographic or prior immunologic history to explain why Ukraine's experience should have been different; the incidence began to decrease within 6 months of the initiation of the mass campaigns, and the rate of decrease was greatest in the oblasts where mass campaigns had been conducted.
Despite the enormous efforts of the Ukrainian government, and assistance from the international community, key management problems with accurately assessing vaccine distribution, consumption, coverage, and wastage persisted throughout the mass immunization period. There were several factors that contributed to these problems. Principal among them were a lack of preparation and capacity at the local level for accurately tracking and accounting for vaccine; loosely defined target populations, vaccination schedules, campaign strategies, and eligibility and contraindication criteria; and nonstandardization of reports and statistics between oblasts. Because of the urgency with which the program was launched, insufficient time was spent in organizing, briefing, and assisting oblast personnel with program goals and strategies. Following the adoption of the universal mass campaign strategy, this lack of planning for monitoring and evaluation became a problem that could not be corrected quickly. It is clear that the international community and the Ukrainian MOH underestimated the readiness of the existing public health structure to undertake these mass vaccination campaigns. The oblasts, which already had no input into the decisions regarding reporting requirements, were also not given adequate feedback or benefits regarding the information they generated. Consequently, compliance, particularly in the first months of the new system, was poor and the numbers often incomplete or inaccurate.
In addition to the inadequate logistic and strategic preparation, there was an unanticipated resistance from some Ukrainian physicians to accept Western vaccine, which is formulated at a lower potency than Russian vaccine. These opponents of the program also rejected the strategy of mass immunization, and some questioned the effectiveness of immunizations, voicing an apparently deep-seated distrust of vaccinations, which was shared by a small but significant proportion of the population. This undercurrent of public distrust of vaccinations is also widespread in Russia, and may be common to all the states of the former Soviet Union.
The situation was made all the more difficult to correct because economic realities, including non-payment of health workers, had resulted in an evolving decentralization of the national public health system, with management authority increasingly located away from Kiev in the oblasts.
In fairness to all partners, the mass immunization program in Ukraine was virtually unique in the history of public health interventions, and many of the obstacles, which now appear to have been inevitable, can be recognized from the clarity of hindsight. The Ukrainian effort at universal adult immunization against diphtheria was the first such effort since the 1976 swine flu immunization program in the United States, and it was only the second time in history that such a national strategy has been adopted.
Conclusions
All available evidence suggests that Ukraine, with the assistance of the international community, was successful in controlling the diphtheria epidemic. The epidemic might have started among children, who had been left vulnerable due to inadequate vaccination coverage, and then quickly spread to inadequately protected adults. The cost of prevention, through strengthening and enforcing a universal program of immunization of infants and children, is far less than the cost of arresting an epidemic once it reaches the general population.
